|
Name |
Benzonitrile
|
Molecular Formula | C7H5N | |
IUPAC Name* |
benzonitrile
|
|
SMILES |
C1=CC=C(C=C1)C#N
|
|
InChI |
InChI=1S/C7H5N/c8-6-7-4-2-1-3-5-7/h1-5H
|
|
InChIKey |
JFDZBHWFFUWGJE-UHFFFAOYSA-N
|
|
Synonyms |
BENZONITRILE; 100-47-0; Cyanobenzene; Phenyl cyanide; Benzenenitrile; Benzoic acid nitrile; Benzene, cyano-; Benzenecarbonitrile; Phenylcyanide; Fenylkyanid; Fenylkyanid [Czech]; NSC 8039; UN2224; AI3-24184; 9V9APP5H5S; C6H5-CN; CHEBI:27991; NSC-8039; Benzonitrile [UN2224] [Poison]; MFCD00001770; DSSTox_CID_1491; DSSTox_RID_76183; DSSTox_GSID_21491; benzonitril; CAS-100-47-0; HSDB 45; CCRIS 3184; EINECS 202-855-7; UNII-9V9APP5H5S; benzo nitrile; 4-cyanobenzene; benzonitrile solvent; WLN: NCR; BENZONITRILE [MI]; bmse000284; BENZONITRILE [HSDB]; EC 202-855-7; SCHEMBL6640; MLS002454387; CHEMBL15819; DTXSID7021491; NSC8039; Benzonitrile, anhydrous, >=99%; HMS3039F17; ZINC899417; Benzonitrile, for HPLC, 99.9%; Tox21_201982; Tox21_302979; Benzonitrile, ReagentPlus(R), 99%; STK398186; AKOS000120125; AM10697; UN 2224; NCGC00091747-01; NCGC00091747-02; NCGC00256387-01; NCGC00259531-01; LS-13256; SMR001372003; B0082; FT-0622719; EN300-19362; C09814; Q412567; J-000140; F1908-0163; Z104473628
|
|
CAS | 100-47-0 | |
PubChem CID | 7505 | |
ChEMBL ID | CHEMBL15819 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 103.12 | ALogp: | 1.6 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 23.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 8 | QED Weighted: | 0.493 |
Caco-2 Permeability: | -4.179 | MDCK Permeability: | 0.00003120 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.06 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.806 | Plasma Protein Binding (PPB): | 71.83% |
Volume Distribution (VD): | 2.338 | Fu: | 17.84% |
CYP1A2-inhibitor: | 0.956 | CYP1A2-substrate: | 0.502 |
CYP2C19-inhibitor: | 0.375 | CYP2C19-substrate: | 0.428 |
CYP2C9-inhibitor: | 0.14 | CYP2C9-substrate: | 0.477 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.403 |
CYP3A4-inhibitor: | 0.015 | CYP3A4-substrate: | 0.316 |
Clearance (CL): | 8.75 | Half-life (T1/2): | 0.816 |
hERG Blockers: | 0.097 | Human Hepatotoxicity (H-HT): | 0.898 |
Drug-inuced Liver Injury (DILI): | 0.276 | AMES Toxicity: | 0.09 |
Rat Oral Acute Toxicity: | 0.087 | Maximum Recommended Daily Dose: | 0.06 |
Skin Sensitization: | 0.38 | Carcinogencity: | 0.605 |
Eye Corrosion: | 0.968 | Eye Irritation: | 0.995 |
Respiratory Toxicity: | 0.291 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000052 | 0.483 | D05OIS | 0.438 | ||||
ENC000064 | 0.483 | D0X9RY | 0.412 | ||||
ENC000014 | 0.438 | D0H0HJ | 0.378 | ||||
ENC000203 | 0.438 | D0T3LF | 0.378 | ||||
ENC000207 | 0.438 | D05BMG | 0.378 | ||||
ENC000204 | 0.438 | D0P9AC | 0.368 | ||||
ENC000012 | 0.438 | D0U0RZ | 0.359 | ||||
ENC000205 | 0.438 | D0R0UJ | 0.357 | ||||
ENC000076 | 0.412 | D0P6UB | 0.350 | ||||
ENC000013 | 0.412 | D01ZJK | 0.350 |